Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Aptamer specifically combined with TNF-R1 as well as screening method and application of aptamer

A TNF-R1, specific binding technology, applied in the field of biomedicine, to achieve the effect of increased washing times, strong specificity, and firm binding

Pending Publication Date: 2020-03-31
ZHENGZHOU UNIV
View PDF8 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this patent document discloses an aptamer that recognizes TNF-α, and there is no report on the DNA aptamer that can specifically bind to the receptor protein of TNF-α—human or mouse TNFR1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aptamer specifically combined with TNF-R1 as well as screening method and application of aptamer
  • Aptamer specifically combined with TNF-R1 as well as screening method and application of aptamer
  • Aptamer specifically combined with TNF-R1 as well as screening method and application of aptamer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043] The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

[0044] Example Screening of aptamers that can specifically bind to TNF-R1

[0045] 1 Construction of random DNA library

[0046] Synthesized by IDT (Integrated DNA Technologies), a DNA library with a full length of 76 nt, 18 bases at both ends as the primer complementary region for each round of screening, and a random region in the middle consisting of 40 bases (denoted by N), after 10% After denaturing polyacrylamide gel electrophoresis (Polyacrylamide Gel Electrophoresis, PAGE...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biological medicines, and relates to an aptamer specifically combined with TNF-R1, in particular to the aptamer specifically combined with TNF-R1 as well as a screening method and an application of the aptamer. The aptamer comprises sequences as shown in SEQ ID No. 1-7 and a plurality of truncated active sequences. The invention also relates to the screening method and the application of the aptamer, seven DNA aptamers capable of being specifically combined with human or mouse TNF receptor protein 1 are screened and separated by using an exponentially enriched ligand phylogenetic technique; the sequence structures are analyzed for further truncation to obtain a DNA fragment with a shortest length for keeping the binding capacity, and throughdot blot hybridization characterization and SPR determination, the seven DNA active sequences can be bound with mouse / human TNFR1 protein, are strong in binding capacity, good in specificity and highin sensitivity, and are not bound with BSA protein.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and relates to an aptamer that specifically binds to TNF-R1, in particular to an aptamer that specifically binds to TNF-R1, and a screening method and application thereof. Background technique [0002] Rheumatoid arthritis (RA) is an immune disorder in which the joint synovium of the sufferer maintains a state of chronic inflammation and gradually loses the ability to move as the disease progresses. So far, RA cannot be completely cured, and the clinical treatment goal is to reduce the joint damage caused by RA and delay the progression of the disease. The pathogenesis of RA is complex, and the most studied pathological factors are cytokines, among which the research on tumor necrosis factor TNF-α and its receptor TNFR is the most mature. [0003] TNF-α is a protein produced by activated monocytes, macrophages and T cells and is highly expressed in the diseased tissues of infected or inflamm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/115C12N15/10A61K31/7088A61K31/712A61P19/02A61P29/00
CPCA61K31/7088A61K31/712A61P19/02A61P29/00C12N15/1048C12N15/115C12N2310/16C12N2310/315C12N2310/321C12N2310/322
Inventor 赵永星顾宏周初骁张楠杜鑫雨
Owner ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com